Navigation Links
IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Date:8/27/2007

ns. In these roles, he managed clinical development activities for a variety of therapeutic areas, including oncology, infectious diseases, women's health, sleep and central nervous system. Prior to Searle/Pharmacia, Dr. Sherman was at Squibb/Bristol-Myers Squibb in Clinical Pharmacology and Clinical Research.

Dr. Sherman received his medical degree from the Rosalind Franklin University/Chicago Medical School. He completed both an internship and residency in internal medicine at the Northwestern University McGaw Medical Center, where he also served as a chief medical resident. In addition, Dr. Sherman completed fellowship training at the University of California, San Francisco (UCSF) and also served as a research associate at the Howard Hughes Medical Institute at UCSF. Dr. Sherman is currently a Board Member of the Drug Information Association (DIA) and will be chairing the DIA 2008 Annual Meeting.

About IDM Pharma

IDM Pharma is focused on the development of innovative cancer products that either destroy cancer cells by activating the immune system or prevent tumor recurrence by triggering a specific adaptive immune response. IDM Pharma is dedicated to maximizing the full therapeutic and commercial potential of each of its innovative products to address the needs of patients and the physicians who treat these patients.

For more information about the company and its products, visit http://www.idm-pharma.com.

Forward-Looking Statements

This press release includes forward-looking statements that reflect management's current views of future events including statements regarding the Company's plans to collect, analyze and submit additional Phase 3 data in an amended NDA for L-MTP-PE and to respond to other matters raised by ODAC and the FDA, the Company's confidence that the proposed NDA amendment will provide substantial evidence for the continued regulatory approval process, the
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... The chemistry, taste, and health effects of tea can vary ... the nonprofit American Botanical Council (ABC). Recent research by ... on the phytochemical compounds in tea ( Camellia sinensis ) ... in the Yunnan province of southwestern ... future of medicinal botanicals. Dr. Ahmed,s report on ...
(Date:9/15/2014)... La deuxième édition annuelle de l, ... sur la sensibilisation au plasma) sera célébrée du ... Plasma Protein Therapeutics Association (PPTA) et ... à : , Sensibiliser davantage la ... plasma-aphérèse , Reconnaître la contribution des donneurs ...
(Date:9/15/2014)... Hydro Dynamics, Inc. (HDI) of Rome, ... will be partnering with Proteaf Technologies (Proteaf) of ... implementing its Shock Wave Power Reactor (SPR) cavitation ... flow chemistry through process intensification has been widely ... for decades. The continuous chemistry has been ...
(Date:9/14/2014)... particularly ingenious when it comes to survival strategies. They ... hostile environment, for example during treatment with antibiotics. A ... a protective slime capsule consisting of sugar chains and ... have for the first time created a detailed three-dimensional ... blocks cross the bacterial cell wall, a crucial step ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... professionals often face the challenge of delivering cost-effective ... both storage and bandwidth efficiency, while providing seamless, ... SecureZip, a new family of products designed for ... a cross-platform environment. The company also introduced a ...
... Inc. announced Wednesday that its net sales are up ... The Milwaukee-based company, which does business as Merge ... the acquisition of RIS Logic, a radiology information systems ... eFilm's picture archiving and communication system, or PACS, used ...
... has announced a new network switch and router ... second, using designs bought from a Wisconsin company. , ... Eau Claire, designs application-specific integrated circuits and systems-on-a-chip. SLE ... System Packet Interface Level 4 Phase 2, or SPI ...
Cached Biology Technology:PKWare launches new enterprise product line, adds new features to PKZip 2PKWare launches new enterprise product line, adds new features to PKZip 3Agilent's new network chip was designed in Wisconsin 2
(Date:9/15/2014)... of wild, domesticated, and domesticated-wild hybridized populations ... found that within 5 to 11 generations, ... wild populations that hybridized with domesticated populations. ... provides evidence that natural selection, over time, ... experience as a result of increased genetic ...
(Date:9/15/2014)... Vuoksi River and the subsequent rapid decrease in the ... revealed thousands of square kilometres of new, fertile land ... University of Helsinki researchers has studied the role that ... interaction between nature and humans. After dramatic shifts in ... changes and gave rise to a new, innovative culture. ...
(Date:9/15/2014)... PA, September 15, 2014 Schizophrenia is generally considered ... shares many risk factors, both genetic and environmental, with ... , The normal path for brain development is determined ... genes and a wide range of environmental factors. , ... patient populations are required in order to map the ...
Breaking Biology News(10 mins):The creation of the Vuoksi River preceded a significant cultural shift 2Brain Development in Schizophrenia Strays from the Normal Path 2
... A mutation in blood stem cells occurs in patients ... at the Moores Cancer Center at the University of ... Cell Biology and Regenerative Medicine and Comprehensive Cancer Center ... The discovery suggests that development of a very specific ...
... colleagues have produced 3-D images of ancient fossils -- 650 ... an achievement that has never been done before. , If ... Earth, Schopf said the techniques he has used, called confocal ... look at microscopic fossils inside the rocks to search for ...
... bone may rely on a few secrets from the ... Berkeley National Laboratory (Berkeley Lab) have harnessed the way ... is four times stronger than material currently used in ... variations of this substance could also be used in ...
Cached Biology News:Mutation in blood stem cells provides clues to cancer development 2Mutation in blood stem cells provides clues to cancer development 3Inside rocks, implications for finding life on Mars 2Secrets of the sea yield stronger artificial bone 2Secrets of the sea yield stronger artificial bone 3Secrets of the sea yield stronger artificial bone 4
UBN-1 (C-20)...
P2A4...
pETDuet-1 is designed for the coexpression of two target genes....
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Biology Products: